LEADER 01936oam  2200517   450 
001 9910715387403321
005 20210520150717.0
035   $a(CKB)5470000002510157
035   $a(OCoLC)1237278482
035   $a(EXLCZ)995470000002510157
100   $a20210211g20219999  ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aProtecting Access to Information for Effective and Necessary Treatment and Services Act $ereport together with dissenting views (to accompany H.R. 3439) (including cost estimate of the Congressional Budget Office)
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d[2021-]
215   $a1 online resource (volumes)
225 1 $aRept. / 116th Congress, 2d session, House of Representatives ;$v116-696
300   $a"December 24, 2020"--Pt. 1.
320   $aIncludes bibliographical references.
517   $aProtecting Access to Information for Effective and Necessary Treatment and Services Act 
606   $aFederal aid to medical research$zUnited States
606   $aHealth insurance$zUnited States
606   $aExpenditures, Public$2fast
606   $aFederal aid to medical research$2fast
606   $aHealth insurance$2fast
607   $aUnited States$2fast
608   $aLegislative materials.$2fast
608   $aLegislative materials.$2lcgft
615  0$aFederal aid to medical research
615  0$aHealth insurance
615  7$aExpenditures, Public.
615  7$aFederal aid to medical research.
615  7$aHealth insurance.
676   $a1.1/8:116-696
801  0$bGPO
801  1$bGPO
801  2$bOCLCF
801  2$bDWP
801  2$bGPO
906   $aBOOK
912   $a9910715387403321
996   $aProtecting Access to Information for Effective and Necessary Treatment and Services Act$93528694
997   $aUNINA